Searched for
MONTELUKAST
IISc researchers find Asthma drug Montelukast can block crucial SARS-CoV-2 proteinApproved by the US Food and Drug Administration (FDA), the drug, called montelukast, has been around for more than 20 years and is usually ...- Morepen gets USFDA nod to market generic anti-allergy drugDrug firm Morepen Laboratories on Friday said it has received approval from the US health regulator to market its anti-allergy drug Fexofin...
- Morepen Labs Q2 results: Net profit up 38% at Rs 37 crore"With massive increase in active pharmaceutical ingredient (API) demand globally and more particularly with frequent supply disruptions fro...
- NPPA tells chief secys to keep tabs on API availabilityIn a letter to the chief secretaries, the National Pharmaceutical Pricing Authority (NPPA) has asked them to ensure that there is no violat...
- Unichem Labs gets USFDA nod for asthma drugThe tablets are indicated for prophylaxis and chronic treatment of asthma in adults and pediatric patients - 12 months of age and older.
- Morepen Labs gets USFDA nod for asthma drugMorepen is the market leader for Montelukast in India with over 50 per cent market share, supplying to almost all major finished dosage man...
- Exports major contributor to API revenues: Sushil Suri, Morepen LabsThe second growth which is coming from in the domestic market is from home diagnostics.
- Aurobindo Pharma, Cadila recall drugs from US marketPantoprazole Sodium delayed-release tablets are used for treatment of erosive inflammation of the esophagus due to acid reflux.
- Morepen to sell anti-asthmatic drug Montelukast in Europe, North AmericaPharma firm Morepen Laboratories today said it is preparing to sell anti-asthmatic drug Montelukast in European and North American markets.
- Ajanta Pharma launches generic asthma treatment tablets in USAjanta Pharma has launched its generic Montelukast Sodium tablets used for treatment of asthma and seasonal allergies in the American marke...
- Unichem gets USFDA nod for generic asthma treatment tabletsDrug firm Unichem Laboratories has received approval from the US health regulator for its Montelukast Sodium tablets used in prevention and...
- Ajanta Pharma gets USFDA nod for generic asthma treatment drugDrug firm Ajanta Pharma has received final approvals from the US health regulator for generic montelukast tablets and oral granules.
- AIIMS doctors write to ICMR for cheaper treatment of diseasesThe success of alternative therapies, has led to speculation that the inexpensive, out of patent drugs may be superior to newer expensive a...
- Jubilant Life gets USFDA nod for generic anti-asthma tablets"This includes 72 ANDAs filed in the US, of which 35 have been approved and 46 dossier filings in Europe. So far, we have received 10 ANDA ...
- Glenmark Generics recalls anti-asthma drug from US marketGlenmark Generics is recalling from the US market multiple lots of Montelukast Sodium tablets (10 mg) on "off-odour" complaints.
- Dr Reddy's Laboratories launches generic anti-asthma drug in US marketDr Reddy's Laboratories has launched its generic Montelukast Sodium oral granules used for treating asthma and seasonal allergies in the US...
- Aurobindo Pharma, Glenmark get FDA nod for generic montelukast sodium tabletsNew Delhi Drug firms Aurobindo Pharma and Glenmark have received approval from the US health regulator to manufacture and market generic mo...
- Aurobindo Pharma, Glenmark get USFDA nod for generic asthma drugAurobindo, Glenmark today said they have received approval from the US health regulator to manufacture, market generic montelukast tablets.
- Indian pharma companies like Aurobindo and Glenmark set to gain from USFDA nod for asthma drugIndian drug makers are set to benefit from a decision by the USFDA to allow sale of generic Singulair tablets used for treating asthma and ...
- Glenmark Pharmaceuticals receives USFDA tentative nod for anti-asthma tabletsGlenmark said it has received tentative approval from the US health regulator to market its tablets used for treating asthma and seasonal a...
Load More
